PERSEUS SOROS BIOPHARMACEUTICAL FUND LP Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for PERSEUS SOROS BIOPHARMACEUTICAL FUND LP.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of PERSEUS SOROS BIOPHARMACEUTICAL FUND LP. PERSEUS SOROS BIOPHARMACEUTICAL FUND LP is a 10% Owner in BIOENVISION INC ($BIV) and a 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).

Address: 888 SEVENTH AVE 30TH FLOOR NEW YORK 10106 NY

Companies in which PERSEUS SOROS BIOPHARMACEUTICAL FUND LP is an Insider

AUXILIUM PHARMACEUTICALS INC

Trading Symbol: AUXL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERSEUS SOROS BIOPHARMACEUTICAL FUND LP: 10% Owner
Holdings: 2,377,403 shares
Latest Transaction: Dec 07 2006

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

BIOENVISION INC

Trading Symbol: BIV
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERSEUS SOROS BIOPHARMACEUTICAL FUND LP: 10% Owner
Holdings: 0 shares
Latest Transaction: Jul 12 2007

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of PERSEUS SOROS BIOPHARMACEUTICAL FUND LP

Sentiment: All, AUXL, BIV

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 12 2007BIVBIOENVISION INCPERSEUS SOROS BIOPHARMACEUTICA ...10% OwnerOption ExerciseJ0.002,250,00000
Jul 12 2007BIVBIOENVISION INCPERSEUS SOROS BIOPHARMACEUTICA ...10% OwnerSellJ5.603,375,04418,900,24603.4 M to 0 (-100.00 %)
May 04 2007BIVBIOENVISION INCPERSEUS SOROS BIOPHARMACEUTICA ...10% OwnerOption ExerciseX6,000,000.0016,000,0000
May 04 2007BIVBIOENVISION INCPERSEUS SOROS BIOPHARMACEUTICA ...10% OwnerBuyX2.003,000,0006,000,0003,375,044375 K to 3.4 M (+799.91 %)
Dec 07 2006AUXLAUXILIUM PHARMACEU ...PERSEUS SOROS BIOPHARMACEUTICA ...10% OwnerSellS16.001,500,00024,000,0002,377,4033.9 M to 2.4 M (-38.69 %)

View all PERSEUS SOROS BIOPHARMACEUTICAL FUND LP insider transactions.